AKT1 and Hepatic steatosis: We show that dysregulation of insulin-mediated IRS–PI3K–Akt signaling pathway results in an imbalance between de novo lipogenesis and mitochondrial β-oxidation, as well as impaired hepatic gluconeogenic pathway, thereby exacerbating fat accumulation and the resultant hepatic steatosis.